TY - JOUR
T1 - Emerging Indications for Interventional Oncology
T2 - Expert Discussion on New Locoregional Treatments
AU - Iezzi, Roberto
AU - Gangi, Afshin
AU - Posa, Alessandro
AU - Pua, Uei
AU - Liang, Ping
AU - Santos, Ernesto
AU - Kurup, Anil N.
AU - Tanzilli, Alessandro
AU - Tenore, Lorenzo
AU - de Leoni, Davide
AU - Filippiadis, Dimitrios
AU - Giuliante, Felice
AU - Valentini, Vincenzo
AU - Gasbarrini, Antonio
AU - Goldberg, Shraga N.
AU - Meijerink, Martijn
AU - Manfredi, Riccardo
AU - Kelekis, Alexis
AU - Colosimo, Cesare
AU - Madoff, David C.
N1 - Publisher Copyright: © 2023 by the authors.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients. Since its advent, due to rapidly evolving research development, its role has expanded to encompass the diagnosis and treatment of diseases across multiple body systems. In detail, interventional oncology is expanding its role across a wide spectrum of disease sites, offering a potential cure, control, or palliative care for many types of cancer patients. Due to its widespread use, a comprehensive review of the new indications for locoregional procedures is mandatory. This article summarizes the expert discussion and report from the “MIOLive Meet SIO” (Society of Interventional Oncology) session during the last MIOLive 2022 (Mediterranean Interventional Oncology Live) congress held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions. The aim of this paper is to provide an updated review of the new techniques and devices available for innovative indications not only to residents and fellows but also to colleagues approaching locoregional treatments.
AB - Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients. Since its advent, due to rapidly evolving research development, its role has expanded to encompass the diagnosis and treatment of diseases across multiple body systems. In detail, interventional oncology is expanding its role across a wide spectrum of disease sites, offering a potential cure, control, or palliative care for many types of cancer patients. Due to its widespread use, a comprehensive review of the new indications for locoregional procedures is mandatory. This article summarizes the expert discussion and report from the “MIOLive Meet SIO” (Society of Interventional Oncology) session during the last MIOLive 2022 (Mediterranean Interventional Oncology Live) congress held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions. The aim of this paper is to provide an updated review of the new techniques and devices available for innovative indications not only to residents and fellows but also to colleagues approaching locoregional treatments.
KW - ablation
KW - bone metastases
KW - breast cancer
KW - cementoplasty
KW - cholangiocellular carcinoma
KW - head and neck cancer
KW - interventional oncology
KW - lymphatics
KW - radioembolization
KW - spinal tumors
UR - http://www.scopus.com/inward/record.url?scp=85145915366&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/cancers15010308
DO - https://doi.org/10.3390/cancers15010308
M3 - Review article
C2 - 36612304
SN - 2072-6694
VL - 15
JO - Cancers
JF - Cancers
IS - 1
M1 - 308
ER -